Search Results for 'vaccines'

Contract Service Directory Companies

View All Buyers Guide Companies »

Contract Service Directory Categories

View All Categories »

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Danaher To Acquire Aldevron for $9.6B

  Aldevron will operate as a standalone operating company and brand within Danaher's Life Sciences segment.

  06.21.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
  

  Eisai, BMS Enter Global Anticancer ADC Alliance

  BMS to pay as much as $2.45B to co-develop Eisai’s MORAb-202

  06.18.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
  

  Sanofi Invests $425M in Flu Vaccine Manufacturing Facility

  Newly licensed U.S. manufacturing facility to increase availability of Fluzone High-Dose Quadrivalent.

  06.17.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Discovery | Industry News
  

  AbSci Acquires Cell Therapy Company Totient

  Combination of Totient technology with AbSci's platform provides framework and data to enable in silico targeted drug design.

  06.17.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
  

  Dendreon Pharmaceuticals Establishes Contract Manufacturing Division

  Now offers end-to-end manufacturing of complex cell therapies and patient logistics for partner programs.

  06.15.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
  

  Ocugen, Jubilant Enter COVID-19 Vaccine Partnership

  Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.

  06.15.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  VERAXA and Quadira Enter ADC Development Partnership

  To develop a suite of novel ADCs for the treatment of oncological conditions.

  06.15.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  Yposkesi to Build Second Commercial Bioproduction Site

  Creates a new global resource for cell & gene therapy with production capacity for early clinical to commercially available biologics.

  06.14.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Trials & Filings
  

  Novavax COVID-19 Vax is 90% Effective in Phase 3 Trial

  NVX-CoV2373 demonstrates 100% protection against moderate and severe disease, 90% efficacy overall, and met the primary endpoint.

  06.14.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
  

  iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance

  GSK now has a leading portfolio of antibodies targeting the CD226 axis, a key target for next-gen immuno-oncology therapies

  06.14.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News | Injectables
  

  BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations

  Company now supplying more than 40 countries for pandemic vaccination campaigns.

  06.11.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
  

  WuXi XDC and LegoChem Ink ADC Agreement

  Sign MOU for the development and manufacturing of antibody-drug conjugates.

  06.11.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Facilities | Industry News
  

  Vibalogics Expands Manufacturing Capacity

  Invests an additional $50 million to further expand cGMP manufacturing capacity for viral vectors.

  06.11.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  ProCell for Patient Project to Develop Automated Production Unit for CAR-T Cell Therapies

  Standardized and automated manufacturing aims to reduce the amount of work on producing CAR-T cells by 50 percent.

  06.10.21
  

  ---

• Biologics, Proteins, Vaccines | Industry News
  

  Pfizer, BioNTech to Provide 500M COVID Vax Doses to U.S. for Donation

  Doses to be donated to approximately 100 low- and lower middle-income countries.

  06.10.21
  

  ---

• Biologics, Proteins, Vaccines | Clinical Trials | Drug Development | Inspections | Process Validation | Risk Management
  

  Establishing Commercial Manufacturing Services for Antibody-Drug Conjugates

  Learn how to properly structure your development work, perform a thorough process risk assessment and prepare for pre-approval inspection audit.

  ---

• Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Industry News
  

  INOVIO, Advaccine Expand COVID Vax Alliance

  To jointly conduct a global Phase 3 segment of the ongoing Phase 2/3 INNOVATE trial evaluating INO-4800 in a two-dose regimen.

  Kristin Brooks 06.08.21
  

  ---

• Biologics, Proteins, Vaccines | Drug Development
  

  Addressing the Need for Standards in Cell and Gene Therapy

  Identifying and understanding the areas with the greatest need for standardization to help the cell and gene industry progress.

  Robert Shaw, Robert Shaw Executive Director, Standards Coordinating Body for Regenerative Medicine 06.07.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  AGC Biologics Inks Supply Deal for COVID-19 Vaccine

  CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.

  Tim Wright, Editor, Contract Pharma 06.07.21
  

  ---

• Biologics, Proteins, Vaccines | Clinical Trials
  

  Gene Therapy Trials

  Answering critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.

  April Marquick, Cell and Gene Therapy Expert, Premier Research 06.07.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
  

  Portonbio Enters CAR-T Partnership with KAEDI

  CDMO will provide KAEDI with CMC services for multiple projects.

  Tim Wright, Editor, Contract Pharma 06.07.21
  

  ---

• Biologics, Proteins, Vaccines
  

  Adapting Manufacturing for Super Small Batch, Precision Medicines

  A look at how the sector can prepare the supply chain for the potentially disruptive trend of personalized medicines.

  Rod Schregardus, Business Development Manager, The Access Group 06.07.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
  

  Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine

  Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.

  Tim Wright, Editor, Contract Pharma 06.07.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  VIVEbiotech Launches Lentiviral Vectors Mfg. Plant

  Increases production capacity by 400% to deliver commercial-size batches for Cell and Gene Therapy Sector.

  Kristin Brooks 06.04.21
  

  ---

• Bioanalytical Services | Bioassay Development | Biologics, Proteins, Vaccines
  

  The Future of Continuous Bioprocessing

  The modernization of advanced therapy manufacturing.

  Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 06.02.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Fill/Finish | Industry News
  

  Moderna, Thermo Fisher Enter COVID Vax Fill/Finish Mfg. Pact

  Thermo will provide aseptic fill/finish, labeling and packaging from its commercial manufacturing site in Greenville, NC.

  Kristin Brooks 06.02.21
  

  ---

• Biologics, Proteins, Vaccines
  

  Avantor Acquires RIM Bio

  Changzhou, China ops become Avantor’s first single-use production facility in AMEA region.

  Kristin Brooks 06.02.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  Lonza, Moderna Expand COVID Vax Mfg. Alliance

  Lonza to support the manufacture of up to an additional 300 million doses per year with install of a new manufacturing line at The Netherlands site.

  Kristin Brooks 06.02.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  CCRM Enters Regenerative Medicine Partnerships

  Signs agreements with Canadian and international institutions to advance regenerative medicine inventions.

  Tim Wright, Editor, Contract Pharma 06.01.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Thibault Jonckheere Named CEO of Exothera

  The viral vector CDMO spinoff of Univercells is making an intranasal vaccine candidate for Covid-19 treatment.

  Tim Wright, Editor, Contract Pharma 06.01.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
  

  Samsung Biologics Expands Vaccine Manufacturing Capabilities

  To add mRNA vaccine drug substance manufacturing suite to expand portfolio of services.

  Tim Wright, Editor, Contract Pharma 06.01.21
  

  ---

• Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
  

  Beroni, tella Sign MoU for Cancer Immunotherapy Treatment

  Will leverage the resources of each party and their respective affiliates to advance tella’s dendritic cell vaccine therapy.

  Kristin Brooks 05.28.21
  

  ---

• Bioanalytical Services | Biologics, Proteins, Vaccines
  

  The Future of Continuous Bioprocessing

  The Modernization of Advanced Therapy Manufacturing

  Dr. Karoline Hahn, Senior Consultant for Advanced Therapies, KCR 05.27.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News
  

  Dyadic Collaborates with Syngene to Develop Covid-19 Vaccine Candidate

  Will develop a candidate to immunize people against current and future variants.

  Charles Sternberg, Assistant Editor 05.26.21
  

  ---

• Biologics, Proteins, Vaccines | Clinical Trials | Drug Development
  

  Gene Therapy Trials

  Critical regulatory and study start-up questions for gene therapy trials in the U.S., UK, and Europe.

  April Marquick, Cell and Gene Therapy Expert, Premier Research 05.26.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid Demand

  One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 vaccine.

  Kristin Brooks 05.26.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
  

  Xeris to Acquire Strongbridge Biopharma

  The two businesses will be combined under a new entity called Xeris Biopharma Holdings, specializing in endocrinology and rare diseases.

  Kristin Brooks 05.24.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  CanSino Biologics Gets OGYÉI GMP Certificate for COVID Vax

  Convidecia has been approved in China, Mexico, Pakistan, Hungary and Chile.

  Kristin Brooks 05.24.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Industry News | Scale-up/Technology Transfer
  

  Moderna, Samsung Biologics Ink COVID Vax Mfg. and Supply Pact

  Samsung Biologics will provide large scale, commercial fill-finish manufacturing for mRNA-1273 from its facilities in Incheon, South Korea.

  Kristin Brooks 05.24.21
  

  ---

• Analytical Services | Bio News | Biologics, Proteins, Vaccines | Breaking News | Drug Development | Facilities | Fill/Finish | Industry News
  

  Resilience Bolsters Canadian Biomanufacturing Site

  Receives $164 million investment from the Government of Canada to modernize and expand Ontario site.

  Tim Wright, Editor, Contract Pharma 05.21.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Pfizer, BioNTech to Supply EU with Additional COMIRNATY Doses

  To supply 900 million doses to European Commission, with option to request an additional 900 million doses, beginning December 2021 – 2023.

  Kristin Brooks 05.20.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Pfizer, BioNTech to Supply Additional COVID-19 Vax Doses to Turkey

  To supply 60 million additional doses of the companies’ COVID-19 vaccine, with an option for an additional 30 million doses to be delivered in 2021.

  Kristin Brooks 05.20.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development
  

  Thermo Fisher, UCSF to Open Cell Therapy cGMP Mfg. Center

  Thermo Fisher will build and operate a 44,000-sq.-ft. cell therapy development, manufacturing and collaboration center on UCSF's Mission Bay campus.

  Kristin Brooks 05.20.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
  

  Gamma Biosciences Acquires Stake in Mirus Bio

  Supports Mirus’ expansion of GMP production of its flagship product TransIT VirusGEN for large scale manufacturing of AAV and LV viral vectors for gene therapy.

  Kristin Brooks 05.18.21
  

  ---

• Bio News | Bioanalytical Services | Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  PerkinElmer Acquires Nexcelom Bioscience

  Bolsters preclinical portfolio and enhances QA/QC capabilities in cell and gene therapy and biologics manufacturing.

  Tim Wright, Editor, Contract Pharma 05.17.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
  

  Humanigen Selects Chime Biologics as Manufacturing Partner

  Ink manufacturing deal for COVID-19 therapeutic candidate lenzilumab.

  Tim Wright, Editor, Contract Pharma 05.17.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | CRO News | Industry News
  

  Charles River to Acquire Vigene Biosciences

  Expands Charles River’s scientific capabilities in the high-growth cell and gene therapy CDMO sector.

  Charles Sternberg, Assistant Editor 05.17.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | Industry News
  

  Avantor Boosts Global Production of Single ­Use Technologies

  To increase single-use manufacturing footprint by 30% and double its cleanroom space in the U.S. and Europe.

  Kristin Brooks 05.14.21
  

  ---

• Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
  

  WuXi Biologics, WuXi STA Establish WuXi XDC JV

  To provide contract development and manufacturing of bioconjugates including antibody-drug conjugates (ADCs).

  Kristin Brooks 05.14.21
  

  ---

• Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
  

  FDA Expands EUA for Pfizer, BioNTech’s Covid-19 Vax

  Expands the authorization to include individuals 12-15 years of age.

  Charles Sternberg, Assistant Editor 05.11.21
  

  ---